CA Stock MarketDetailed Quotes

MSCL Satellos Bioscience Inc

Watchlist

0.750
-0.060-7.41%

15min DelayMarket Closed Nov 22 16:00 ET

85.20MMarket Cap-3000P/E (TTM)

Satellos Bioscience Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-47.08%23.42M

-43.15%27.7M

1,011.48%33.17M

1,957.54%39.59M

1,313.86%44.26M

2,424.01%48.73M

7.53%2.98M

-60.50%1.92M

-Cash and cash equivalents

-47.08%23.42M

-79.83%9.83M

339.42%13.11M

1,046.93%22.07M

1,313.86%44.26M

2,424.01%48.73M

7.53%2.98M

-60.50%1.92M

-Short term investments

--0

--17.87M

--20.06M

--17.52M

----

Receivables

-46.20%191K

180.14%1M

1,288.78%895K

124.23%583K

68.20%355K

69.46%358.39K

-88.44%64.45K

-50.76%260K

-Accounts receivable

----

9,860.24%177.59K

----

-Taxes receivable

-46.20%191K

455.31%1M

1,288.78%895K

124.23%583K

68.20%355K

-13.79%180.8K

-88.41%64.45K

-50.59%260K

Prepaid assets

682.43%579K

3,810.74%510K

547.68%209K

221.74%148K

25.45%74K

-44.37%13.04K

33.28%32.27K

5.44%46K

Hedging assets-current

--0

-18.30%1K

55.93%3K

33.33%4K

--6K

--1.22K

--1.92K

--3K

Total current assets

-45.88%24.19M

-40.50%29.21M

1,011.83%34.28M

1,705.73%40.32M

1,214.38%44.7M

2,167.38%49.1M

-8.17%3.08M

-58.97%2.23M

Non current assets

Net PPE

-15.00%17K

58.86%20K

171.39%19K

111.11%19K

120.48%20K

61.53%12.59K

-19.01%7K

9.86%9K

-Gross PPE

-15.00%17K

-2.07%20K

40.15%19K

128.57%32K

120.48%20K

162.03%20.42K

56.84%13.56K

38.78%14K

-Accumulated depreciation

----

-160.00%-13K

----

---7.83K

---6.56K

-163.71%-5K

Investments and advances

--0

0.77%43K

0.53%42K

-2.38%41K

--42K

--42.67K

--41.78K

--42K

Goodwill and other intangible assets

--0

-0.00%3.92M

0.00%3.92M

-42.53%3.92M

-43.42%3.92M

-44.29%3.92M

-45.12%3.92M

Total non current assets

-99.57%17K

0.19%3.98M

0.30%3.98M

0.23%3.98M

-41.69%3.98M

-42.69%3.97M

-43.66%3.96M

-44.47%3.97M

Total assets

-50.27%24.21M

-37.46%33.19M

442.78%38.26M

614.60%44.3M

376.13%48.68M

483.51%53.07M

-32.20%7.05M

-50.75%6.2M

Liabilities

Current liabilities

Current debt and capital lease obligation

----

--178.88K

--183.43K

----

-Current debt

----

--178.88K

--183.43K

----

Payables

36.15%1.37M

110.12%1.59M

7.60%1.75M

-29.06%1.04M

-28.56%1.01M

-23.51%758.16K

80.92%1.62M

29.87%1.47M

-accounts payable

36.15%1.37M

110.12%1.59M

7.60%1.75M

-29.06%1.04M

-28.56%1.01M

-23.51%758.16K

80.92%1.62M

29.87%1.47M

Current accrued expenses

71.83%2.25M

132.46%2.43M

58.20%2.01M

89.44%2.58M

115.27%1.31M

-4.08%1.05M

89.06%1.27M

39.87%1.36M

Current liabilities

56.32%3.62M

102.97%4.03M

22.05%3.75M

28.06%3.62M

14.81%2.32M

-4.74%1.98M

96.09%3.08M

34.51%2.83M

Non current liabilities

Long term debt and capital lease obligation

----

--1.9M

--1.84M

----

-Long term debt

----

--1.9M

--1.84M

----

Total non current liabilities

--0

--1.9M

--1.84M

--0

Total liabilities

56.32%3.62M

3.77%4.03M

-23.69%3.75M

28.06%3.62M

14.81%2.32M

86.33%3.88M

213.63%4.92M

34.51%2.83M

Shareholders'equity

Share capital

0.54%62.25M

0.04%61.94M

103.44%61.92M

104.96%61.92M

104.91%61.92M

118.66%61.92M

7.48%30.43M

6.69%30.21M

-common stock

0.54%62.25M

0.04%61.94M

103.44%61.92M

104.96%61.92M

104.91%61.92M

118.66%61.92M

7.48%30.43M

6.69%30.21M

Additional paid-in capital

93.81%7.74M

129.91%7.46M

135.35%6.77M

36.09%5.02M

-11.92%3.99M

-2.82%3.25M

-1.52%2.88M

198.50%3.69M

Retained earnings

-69.63%-69.5M

-61.65%-60.45M

-63.50%-54.41M

-50.26%-47.5M

-54.35%-40.97M

-51.74%-37.39M

-48.52%-33.28M

-55.80%-31.61M

Gains losses not affecting retained earnings

-9.09%-12K

-162.35%-23K

-80.20%-15K

-114.29%-15K

-1,556.63%-11K

-14,472.13%-8.77K

-165.94%-8.32K

-384.76%-7K

Other equity interest

-6.18%20.11M

-5.58%20.24M

861.62%20.24M

1,846.52%21.26M

--21.43M

--2.1M

-10.74%1.09M

Total stockholders'equity

-55.59%20.59M

-40.71%29.17M

1,520.99%34.5M

1,107.30%40.67M

465.00%46.36M

601.48%49.19M

-75.89%2.13M

-67.86%3.37M

Total equity

-55.59%20.59M

-40.71%29.17M

1,520.99%34.5M

1,107.30%40.67M

465.00%46.36M

601.48%49.19M

-75.89%2.13M

-67.86%3.37M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-47.08%23.42M	-43.15%27.7M	1,011.48%33.17M	1,957.54%39.59M	1,957.54%39.59M	1,313.86%44.26M	2,424.01%48.73M	7.53%2.98M	-60.50%1.92M	-60.50%1.92M
-Cash and cash equivalents	-47.08%23.42M	-79.83%9.83M	339.42%13.11M	1,046.93%22.07M	1,046.93%22.07M	1,313.86%44.26M	2,424.01%48.73M	7.53%2.98M	-60.50%1.92M	-60.50%1.92M
-Short term investments	--0	--17.87M	--20.06M	--17.52M	--17.52M	----	----	----	----	----
Receivables	-46.20%191K	180.14%1M	1,288.78%895K	124.23%583K	124.23%583K	68.20%355K	69.46%358.39K	-88.44%64.45K	-50.76%260K	-50.76%260K
-Accounts receivable	----	----	----	----	----	----	9,860.24%177.59K	----	----	----
-Taxes receivable	-46.20%191K	455.31%1M	1,288.78%895K	124.23%583K	124.23%583K	68.20%355K	-13.79%180.8K	-88.41%64.45K	-50.59%260K	-50.59%260K
Prepaid assets	682.43%579K	3,810.74%510K	547.68%209K	221.74%148K	221.74%148K	25.45%74K	-44.37%13.04K	33.28%32.27K	5.44%46K	5.44%46K
Hedging assets-current	--0	-18.30%1K	55.93%3K	33.33%4K	33.33%4K	--6K	--1.22K	--1.92K	--3K	--3K
Total current assets	-45.88%24.19M	-40.50%29.21M	1,011.83%34.28M	1,705.73%40.32M	1,705.73%40.32M	1,214.38%44.7M	2,167.38%49.1M	-8.17%3.08M	-58.97%2.23M	-58.97%2.23M
Non current assets
Net PPE	-15.00%17K	58.86%20K	171.39%19K	111.11%19K	111.11%19K	120.48%20K	61.53%12.59K	-19.01%7K	9.86%9K	9.86%9K
-Gross PPE	-15.00%17K	-2.07%20K	40.15%19K	128.57%32K	128.57%32K	120.48%20K	162.03%20.42K	56.84%13.56K	38.78%14K	38.78%14K
-Accumulated depreciation	----	----	----	-160.00%-13K	-160.00%-13K	----	---7.83K	---6.56K	-163.71%-5K	-163.71%-5K
Investments and advances	--0	0.77%43K	0.53%42K	-2.38%41K	-2.38%41K	--42K	--42.67K	--41.78K	--42K	--42K
Goodwill and other intangible assets	--0	-0.00%3.92M	-0.00%3.92M	0.00%3.92M	0.00%3.92M	-42.53%3.92M	-43.42%3.92M	-44.29%3.92M	-45.12%3.92M	-45.12%3.92M
Total non current assets	-99.57%17K	0.19%3.98M	0.30%3.98M	0.23%3.98M	0.23%3.98M	-41.69%3.98M	-42.69%3.97M	-43.66%3.96M	-44.47%3.97M	-44.47%3.97M
Total assets	-50.27%24.21M	-37.46%33.19M	442.78%38.26M	614.60%44.3M	614.60%44.3M	376.13%48.68M	483.51%53.07M	-32.20%7.05M	-50.75%6.2M	-50.75%6.2M
Liabilities
Current liabilities
Current debt and capital lease obligation	----	----	----	----	----	----	--178.88K	--183.43K	----	----
-Current debt	----	----	----	----	----	----	--178.88K	--183.43K	----	----
Payables	36.15%1.37M	110.12%1.59M	7.60%1.75M	-29.06%1.04M	-29.06%1.04M	-28.56%1.01M	-23.51%758.16K	80.92%1.62M	29.87%1.47M	29.87%1.47M
-accounts payable	36.15%1.37M	110.12%1.59M	7.60%1.75M	-29.06%1.04M	-29.06%1.04M	-28.56%1.01M	-23.51%758.16K	80.92%1.62M	29.87%1.47M	29.87%1.47M
Current accrued expenses	71.83%2.25M	132.46%2.43M	58.20%2.01M	89.44%2.58M	89.44%2.58M	115.27%1.31M	-4.08%1.05M	89.06%1.27M	39.87%1.36M	39.87%1.36M
Current liabilities	56.32%3.62M	102.97%4.03M	22.05%3.75M	28.06%3.62M	28.06%3.62M	14.81%2.32M	-4.74%1.98M	96.09%3.08M	34.51%2.83M	34.51%2.83M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	----	--1.9M	--1.84M	----	----
-Long term debt	----	----	----	----	----	----	--1.9M	--1.84M	----	----
Total non current liabilities	--0	--0	--0	--0	--0	--0	--1.9M	--1.84M	--0	--0
Total liabilities	56.32%3.62M	3.77%4.03M	-23.69%3.75M	28.06%3.62M	28.06%3.62M	14.81%2.32M	86.33%3.88M	213.63%4.92M	34.51%2.83M	34.51%2.83M
Shareholders'equity
Share capital	0.54%62.25M	0.04%61.94M	103.44%61.92M	104.96%61.92M	104.96%61.92M	104.91%61.92M	118.66%61.92M	7.48%30.43M	6.69%30.21M	6.69%30.21M
-common stock	0.54%62.25M	0.04%61.94M	103.44%61.92M	104.96%61.92M	104.96%61.92M	104.91%61.92M	118.66%61.92M	7.48%30.43M	6.69%30.21M	6.69%30.21M
Additional paid-in capital	93.81%7.74M	129.91%7.46M	135.35%6.77M	36.09%5.02M	36.09%5.02M	-11.92%3.99M	-2.82%3.25M	-1.52%2.88M	198.50%3.69M	198.50%3.69M
Retained earnings	-69.63%-69.5M	-61.65%-60.45M	-63.50%-54.41M	-50.26%-47.5M	-50.26%-47.5M	-54.35%-40.97M	-51.74%-37.39M	-48.52%-33.28M	-55.80%-31.61M	-55.80%-31.61M
Gains losses not affecting retained earnings	-9.09%-12K	-162.35%-23K	-80.20%-15K	-114.29%-15K	-114.29%-15K	-1,556.63%-11K	-14,472.13%-8.77K	-165.94%-8.32K	-384.76%-7K	-384.76%-7K
Other equity interest	-6.18%20.11M	-5.58%20.24M	861.62%20.24M	1,846.52%21.26M	1,846.52%21.26M	--21.43M	--21.43M	--2.1M	-10.74%1.09M	-10.74%1.09M
Total stockholders'equity	-55.59%20.59M	-40.71%29.17M	1,520.99%34.5M	1,107.30%40.67M	1,107.30%40.67M	465.00%46.36M	601.48%49.19M	-75.89%2.13M	-67.86%3.37M	-67.86%3.37M
Total equity	-55.59%20.59M	-40.71%29.17M	1,520.99%34.5M	1,107.30%40.67M	1,107.30%40.67M	465.00%46.36M	601.48%49.19M	-75.89%2.13M	-67.86%3.37M	-67.86%3.37M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

MSCL Satellos Bioscience Inc

Satellos Bioscience Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow